A Study of IW-6463 in Healthy Volunteers
NCT03856827
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Other
Interventions
DRUG:
IW-6463
DRUG:
Matching Placebo
Sponsor
Tisento Therapeutics